BRAF 抗体
Recommended next Filters:
您想试用我们的人工智能搜索吗?
207 results
Latest Publications for our BRAF 抗体
: "Protein expression of KIT, BRAF, GNA11, GNAQ and RASSF1 in feline diffuse iris melanomas." in: Veterinary journal (London, England : 1997), Vol. 249, pp. 33-40, (2019) (PubMed).: "Histologic and immunohistochemical predictors of clinical behavior for feline diffuse iris melanoma." in: Veterinary ophthalmology, Vol. 19 Suppl 1, pp. 44-55, (2016) (PubMed).
: "HNF4? is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer." in: Gut, (2014) (PubMed).
: "Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma." in: Molecular & cellular proteomics : MCP, Vol. 12, Issue 5, pp. 1335-49, (2013) (PubMed).
: "TRIM59, a novel multiple cancer biomarker for immunohistochemical detection of tumorigenesis." in: BMJ open, Vol. 2, Issue 5, (2012) (PubMed).
: "BRAF drives synovial fibroblast transformation in rheumatoid arthritis." in: The Journal of biological chemistry, Vol. 285, Issue 45, pp. 34299-303, (2010) (PubMed).
: "Calcineurin increases glucose activation of ERK1/2 by reversing negative feedback." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Issue 51, pp. 22314-9, (2010) (PubMed).
: "Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, Issue 35, pp. 5705-12, (2008) (PubMed).
: "The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane." in: Endocrine-related cancer, Vol. 13, Issue 1, pp. 257-69, (2006) (PubMed).
: "Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma." in: Annals of surgery, Vol. 244, Issue 5, pp. 799-804, (2006) (PubMed).
Aliases for BRAF 抗体
B-Raf proto-oncogene, serine/threonine kinase (BRAF) 抗体B-Raf proto-oncogene, serine/threonine kinase (Braf) 抗体
B-Raf proto-oncogene, serine/threonine kinase S homeolog (braf.S) 抗体
B-Raf proto-oncogene, serine/threonine kinase (braf) 抗体
Braf transforming gene (Braf) 抗体
si:dkey-222f8.3 (si:dkey-222f8.3) 抗体
9930012E13Rik 抗体
AA120551 抗体
AA387315 抗体
AA473386 抗体
B-Raf 抗体
B-raf 抗体
B-RAF1 抗体
b-raf1 抗体
BRAF 抗体
braf 抗体
Braf-2 抗体
BRAF1 抗体
braf1 抗体
Braf2 抗体
C-RMIL 抗体
C87398 抗体
C230098H17 抗体
D6Ertd631e 抗体
fc48g01 抗体
NS7 抗体
RAFB1 抗体
rafb1 抗体
RMIL 抗体
sierrabraf 抗体
wu:fc48g01 抗体
您还需要查找其他产品吗?
- BPY2 抗体
 - BPTF 抗体
 - BPNT1 抗体
 - BPIL1 抗体
 - BPIFB4 抗体
 - BPIFB3 抗体
 - BPIFB1 抗体
 - BPIFA2 抗体
 - BPIFA1 抗体
 - BPI 抗体
 - BPHL 抗体
 - BPGM 抗体
 - Botulinum Neurotoxin Type B 抗体
 - BORA 抗体
 - Bone Morphogenetic Protein Receptor 1A 抗体
 - BOLL 抗体
 - BOLA3 抗体
 - BOLA2 抗体
 - BOLA1 抗体
 - BOK 抗体
 
- Branched Chain Amino-Acid Transaminase 1, Cytosolic 抗体
 - BRAP 抗体
 - BRCA1 抗体
 - BRCA2 抗体
 - BRCAA1 抗体
 - BRCC3 抗体
 - BRD1 抗体
 - BRD2 抗体
 - BRD3 抗体
 - BRD4 抗体
 - BRD7 抗体
 - BRD8 抗体
 - BRD9 抗体
 - BRDT 抗体
 - BRE 抗体
 - BRF1, RNA polymerase III transcription initiation factor subunit 抗体
 - BRF2 抗体
 - BRI3BP 抗体
 - BRIP1 抗体
 - BRISC and BRCA1 A Complex Member 1 抗体